专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08765197B2 Extract of herbal and composition containing the same 有权
标题翻译：提取物含有相同的草药和成分
公开(公告)号：US08765197B2
公开(公告)日：2014-07-01
申请号：US12224327
申请日：2007-02-27
申请人： Mi Won Son , Sang Jin Choi , Chong Hwan Cho , Nam Joon Baek , Tae Ho Lee , Jae Keol Rhee , Soon Hoe Kim , Moo Hi Yoo , Mi Rim Jin , Jin Pub Son
发明人： Mi Won Son , Sang Jin Choi , Chong Hwan Cho , Nam Joon Baek , Tae Ho Lee , Jae Keol Rhee , Soon Hoe Kim , Moo Hi Yoo , Mi Rim Jin , Jin Pub Son
IPC分类号： A61K36/00 , A61K36/31
CPC分类号： A23L2/52 , A23L33/105 , A61K36/31 , A61K36/39 , A61K36/505 , A61K36/56 , A61K2300/00
摘要： The present invention relates to herbal extracts of Sinapis Semen, Corydalis Tuber, Pharbitidis Seed, and Strychni Ignatii Semen, and a composition containing the same for treating and preventing gastrointestinal motility disorder. The extracts of the present invention have a remarkable effect of promoting gastrointestinal motility through HT3 receptor antagonism and/or HT4 receptor antagonism.
摘要翻译：本发明涉及Sinapis Semen，Corydalis Tuber，Pharbitidis Seed和Strychni Ignatii Semen的草药提取物，以及含有它们的用于治疗和预防胃肠蠕动障碍的组合物。本发明的提取物具有通过HT3受体拮抗作用和/或HT4受体拮抗作用促进胃肠蠕动的显着效果。

2. 发明申请

US20090186108A1 EXTRACT OF HERBAL AND COMPOSITION CONTAINING THE SAME 有权
标题翻译：含有其的草药和组合物的提取物
公开(公告)号：US20090186108A1
公开(公告)日：2009-07-23
申请号：US12224327
申请日：2007-02-27
申请人： Mi Won Son , Sang Jin Choi , Chong Hwan Cho , Nam Joon Baek , Tae Ho Lee , Jae Keol Rhee , Soon Hoe Kim , Moo Hi Yoo , Mi Rim Jin , Jin Pub Son
发明人： Mi Won Son , Sang Jin Choi , Chong Hwan Cho , Nam Joon Baek , Tae Ho Lee , Jae Keol Rhee , Soon Hoe Kim , Moo Hi Yoo , Mi Rim Jin , Jin Pub Son
IPC分类号： A61K36/31 , A61K36/00 , A61P1/14
CPC分类号： A23L2/52 , A23L33/105 , A61K36/31 , A61K36/39 , A61K36/505 , A61K36/56 , A61K2300/00
摘要： The present invention relates to herbal extracts of Sinapis Semen, Corydalis Tuber, Pharbitidis Seed, and Strychni Ignatii Semen, and a composition containing the same for treating and preventing gastrointestinal motility disorder. The extracts of the present invention have a remarkable effect of promoting gastrointestinal motility through HT3 receptor antagonism and/or HT4 receptor antagonism.
摘要翻译：本发明涉及Sinapis Semen，Corydalis Tuber，Pharbitidis Seed和Strychni Ignatii Semen的草药提取物，以及含有它们的用于治疗和预防胃肠蠕动障碍的组合物。本发明的提取物具有通过HT3受体拮抗作用和/或HT4受体拮抗作用促进胃肠蠕动的显着效果。

3. 发明授权

US07816379B2 Oxazolidinone derivatives 有权
标题翻译：恶唑烷酮衍生物
公开(公告)号：US07816379B2
公开(公告)日：2010-10-19
申请号：US10596412
申请日：2004-12-17
申请人： Jae Keol Rhee , Weon Bin Im , Chong Hwan Cho , Sung Hak Choi , Tae Ho Lee
发明人： Jae Keol Rhee , Weon Bin Im , Chong Hwan Cho , Sung Hak Choi , Tae Ho Lee
IPC分类号： A61K31/4439 , C07D413/14
CPC分类号： A61K31/4439 , A61K31/675 , C07D263/32 , C07D413/14 , C07D417/10 , C07D417/14 , C07F9/653 , C07F9/65583
摘要： The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.
摘要翻译：本发明涉及恶唑烷酮的新衍生物，其方法和药物组合物，其包含用于抗生素的衍生物。本发明的恶唑烷酮衍生物显示出对广谱细菌的抑制活性和较低的毒性。通过使具有羟基的化合物与氨基酸或磷酸酯反应制备的前药在对水的溶解性方面具有优异的效果。此外，本发明的衍生物可以相对于各种人和动物病原体，包括葡萄球菌，肠球菌和链球菌等革兰阳性菌，拟杆菌和梭菌等厌氧菌，耐结核菌如结核分枝杆菌和鸟分枝杆菌。因此，包含恶唑烷酮的组合物用于抗生素中。

4. 发明申请

US20090192197A1 NOVEL OXAZOLIDINONE DERIVATIVES 有权
标题翻译：新型氧杂环丁酮衍生物
公开(公告)号：US20090192197A1
公开(公告)日：2009-07-30
申请号：US12211655
申请日：2008-09-16
申请人： Jae Keol Rhee , Weon Bin Im , Chong Hwan Cho , Sung Hak Choi , Tae Ho Lee
发明人： Jae Keol Rhee , Weon Bin Im , Chong Hwan Cho , Sung Hak Choi , Tae Ho Lee
IPC分类号： A61K31/4439 , C07D413/14 , A61P3/04
CPC分类号： A61K31/4439 , A61K31/675 , C07D263/32 , C07D413/14 , C07D417/10 , C07D417/14 , C07F9/653 , C07F9/65583
摘要： The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.
摘要翻译：本发明涉及恶唑烷酮的新衍生物，其方法和药物组合物，其包含用于抗生素的衍生物。本发明的恶唑烷酮衍生物显示出对广谱细菌的抑制活性和较低的毒性。通过使具有羟基的化合物与氨基酸或磷酸酯反应制备的前药在对水的溶解性方面具有优异的效果。此外，本发明的衍生物可以相对于各种人和动物病原体，包括葡萄球菌，肠球菌和链球菌等革兰阳性菌，拟杆菌和梭菌等厌氧菌，耐结核菌如结核分枝杆菌和鸟分枝杆菌。因此，包含恶唑烷酮的组合物用于抗生素中。

5. 发明授权

US08420676B2 Oxazolidinone derivatives 有权
标题翻译：恶唑烷酮衍生物
公开(公告)号：US08420676B2
公开(公告)日：2013-04-16
申请号：US12211655
申请日：2008-09-16
申请人： Jae Keol Rhee , Weon Bin Im , Chong Hwan Cho , Sung Hak Choi , Tae Ho Lee
发明人： Jae Keol Rhee , Weon Bin Im , Chong Hwan Cho , Sung Hak Choi , Tae Ho Lee
IPC分类号： A61K31/4439 , C07D413/14
CPC分类号： A61K31/4439 , A61K31/675 , C07D263/32 , C07D413/14 , C07D417/10 , C07D417/14 , C07F9/653 , C07F9/65583
摘要： The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone derivatives of the present invention show inhibitory activity against a broad spectrum of bacteria and lower toxicity. The prodrugs, prepared by reacting the compound having hydroxyl group with amino acid or phosphate, have an excellent efficiency on solubility thereof against water. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as, Staphylococci, Enterococci and Streptococci anaerobic microorganisms such as Bacteroides and Clostridia, and acid-resistant microorganisms such as Mycobacterium tuberculosis and Mycobacterium avium. Accordingly, the compositions comprising the oxazolidinone are used in an antibiotic.
摘要翻译：本发明涉及恶唑烷酮的新衍生物，其方法和药物组合物，其包含用于抗生素的衍生物。本发明的恶唑烷酮衍生物显示出对广谱细菌的抑制活性和较低的毒性。通过使具有羟基的化合物与氨基酸或磷酸酯反应制备的前药在对水的溶解性方面具有优异的效果。此外，本发明的衍生物相对于各种人和动物病原体，包括革兰氏阳性菌如葡萄球菌，肠球菌和链球菌厌氧微生物如拟杆菌和梭菌，以及耐酸微生物如结核分枝杆菌和鸟分枝杆菌。因此，包含恶唑烷酮的组合物用于抗生素中。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式